Shenzhen New Industries Biomedical Engineering Co., Ltd.
新产业
300832
Shenzhen Stock Exchange
Company Overview
Shenzhen New Industries Biomedical Engineering Co., Ltd. is a manufacturing company listed on the ChiNext board of the Shenzhen Stock Exchange since 2020. The company specializes in the research, development, production, and sales of in-vitro diagnostic products, providing essential diagnostic information for medical applications including disease prevention, diagnosis, treatment, and health assessments. With a customer-centered approach, Shenzhen New Industries focuses on continuous innovation to enhance its product offerings and services. The company's operations are anchored in four major technical R&D platforms, which include magnetic nanospheres, critical raw materials for reagents, diagnostic instruments, and reagents. Shenzhen New Industries offers a diverse range of products, including 12 types of automatic chemiluminescence immunoassay analyzers and a variety of supporting reagents for various medical tests. The company has established a robust marketing network, supplying products to over 1,800 domestic hospitals and serving customers in 161 countries. Its commitment to quality is reflected in its adherence to stringent production standards and comprehensive after-sales service systems.
AI-generated from company disclosures and CNInfo data.
Company Profile
1. Strengths in Complete R&D System of the Industry Chain Having specialized in research and development of in-vitro diagnostic products for 30 years, we have built four major technical R&D platforms for magnetic nanospheres, critical raw materials of reagents, diagnostic instruments and reagents. The complete R&D platforms of our industry chain can effectively increase the efficiency of new product R&D, speed up upgrading/iteration of existing products, and constantly improve product quality and performances, so as to satisfy the end users'needs. 2. Competitive Advantages in a Series of Products Adopting R&D strategies for serializing our instruments, we supply 12 types of automatic chemiluminescence immunoassay analyzers, which include low-speed, medium-speed and high-speed models for satisfying different customer requirements. The MAGLUMI X10 analyzer can perform 1000 tests per hour.The reagents for chemiluminescence immunoassay sold by us worldwide include multiple varieties and 239 types, which are specific to tumor markers, thyroid, fertility, infectious diseases, inflammation monitoring, hepatic fibrosis, bone metabolism and glyco metabolism. 196 out of these 239 types of reagents have been registered in China. As chemiluminescence immunoassay system is closed, diverse instruments and complete reagent menus will effectively enhance our product competitiveness. 3. Strengths in the Worldwide Marketing Network Having constructed a marketing network which covers the key markets at home and abroad.So far, we have sold our products to 1,875 tertiary hospitals of China. The sustained growth of our installed capacity will lay a solid foundation for driving our future sales of reagents. After approximately 10 years of continuous hard work in the overseas markets, we have occupied striking leading advantages in our chemiluminescence products. Up till now, we have cumulatively sold instruments in 161 countries and regions. Our stable customer base has also driven steady increase in our overseas sales revenues of reagents. 4. Strengths in Professional and Timely after-sales Services High-quality after-sales services are important guarantees for our product competitiveness. Through years of efforts, we have constructed a nationwide after-sales service network which covers Xinjiang and Tibet. This network has enabled us to promptly respond to customer needs for services within 48 hours and guarantees quality of after-sales services. In addition, we establish our professional training system dependent upon R&D platforms to perform systematic skills training for our after-sales service engineers, who are managed according to their skill level, so precise services are provided for customers based on how difficult the services are, in order to promptly and accurately solve all after-sales problems. 5. Strengths in Reserves of Technical Talents Upholding the core values of “shouldering heavy missions bravely, enjoy challenging and pursuing excellence”, we have cultivated multidisciplinary, hierarchical and well-structured talents for research, development, technical production, product promotion and after-sales services after 30 years of independent research and development. Having established a polycentric skill level evaluation system, we have built and reserved an echelon of professional talents for supporting our continuous development. Our R&D team has made prominent achievements in technology and process innovations.
Key Financials
As of 2026-07-25T00:00:00.000+00:00Announcements
Notes & Comments
Sign in to leave a comment or private note.
No notes or comments yet.